NASDAQ:BSTC - BioSpecifics Technologies SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$60.83 -1.33 (-2.14 %)
(As of 05/23/2019 04:00 PM ET)
Previous Close$62.16
Today's Range$59.52 - $63.98
52-Week Range$40.58 - $73.31
Volume45,867 shs
Average Volume53,661 shs
Market Capitalization$442.72 million
P/E Ratio22.28
Dividend YieldN/A
Beta1.27

SEC Filings

BioSpecifics Technologies (NASDAQ:BSTC) SEC Filings

DateFilerForm TypeView
05/23/2019
4:34 PM
BioSpecifics Technologies (Issuer)
Chao Jennifer M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/23/2019
4:13 PM
BioSpecifics Technologies (Issuer)
Wegman Mark N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/23/2019
2:33 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/22/2019
2:46 PM
BioSpecifics Technologies (Issuer)
Wegman Toby (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/22/2019
1:51 PM
BioSpecifics Technologies (Issuer)
Wegman Mark N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/21/2019
8:46 PM
BioSpecifics Technologies (Issuer)
Chao Jennifer M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/21/2019
3:06 PM
BioSpecifics Technologies (Issuer)
Chao Jennifer M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/17/2019
4:47 PM
BioSpecifics Technologies (Issuer)
Wegman Mark N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/17/2019
2:13 PM
BioSpecifics Technologies (Issuer)
Gitman Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/10/2019
3:01 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/10/2019
1:25 PM
BioSpecifics Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/03/2019
12:38 PM
BioSpecifics Technologies (Filer)
Form DEFA14A
View Filing
04/30/2019
1:50 PM
BioSpecifics Technologies (Filer)
Form DEF 14A
View Filing
04/10/2019
2:46 PM
BioSpecifics Technologies (Issuer)
CALDWELL PATRICK M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
04/02/2019
12:00 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/02/2019
10:51 AM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/18/2019
3:36 PM
BioSpecifics Technologies (Filer)
Form NT 10-K
View Filing
03/18/2019
12:15 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/28/2019
2:10 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/21/2019
12:06 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/19/2019
10:03 AM
BioSpecifics Technologies (Subject)
Vogel Jeffrey Kenneth (Filed by)
Form SC 13G
View Filing
02/13/2019
3:14 PM
BioSpecifics Technologies (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G/A
View Filing
02/01/2019
5:47 PM
BioSpecifics Technologies (Issuer)
Law Ronald Edward (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
01/24/2019
7:39 AM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/16/2018
4:20 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/09/2018
4:12 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/09/2018
12:08 PM
BioSpecifics Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/01/2018
1:02 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/11/2018
8:23 PM
BioSpecifics Technologies (Issuer)
Wegman Mark N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/07/2018
4:31 PM
BioSpecifics Technologies (Issuer)
Gitman Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/30/2018
4:36 PM
BioSpecifics Technologies (Issuer)
Schamroth Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/29/2018
4:53 PM
BioSpecifics Technologies (Issuer)
Gitman Paul (Reporting)
Form 4/A
View Filing
08/29/2018
4:51 PM
BioSpecifics Technologies (Issuer)
Gitman Paul (Reporting)
Form 4/A
View Filing
08/29/2018
3:20 PM
BioSpecifics Technologies (Issuer)
Gitman Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/27/2018
7:35 PM
BioSpecifics Technologies (Issuer)
Gitman Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/24/2018
3:22 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/23/2018
7:36 PM
BioSpecifics Technologies (Issuer)
Wegman Mark N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/17/2018
6:50 PM
BioSpecifics Technologies (Issuer)
Estate of Edwin H. Wegman (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/17/2018
6:48 PM
BioSpecifics Technologies (Issuer)
Wegman Toby (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/17/2018
6:47 PM
BioSpecifics Technologies (Issuer)
Wegman Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/15/2018
8:02 PM
BioSpecifics Technologies (Issuer)
Wegman Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/09/2018
3:08 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/09/2018
12:48 PM
BioSpecifics Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/02/2018
8:38 PM
BioSpecifics Technologies (Issuer)
Wegman Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/03/2018
7:32 AM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/20/2018
7:20 PM
BioSpecifics Technologies (Issuer)
Wegman Mark N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/04/2018
8:08 PM
BioSpecifics Technologies (Issuer)
Schamroth Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/24/2018
7:53 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/10/2018
2:03 PM
BioSpecifics Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
04/06/2018
3:54 PM
BioSpecifics Technologies (Filer)
Form 8-K/A
View Filing
03/26/2018
3:41 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/19/2018
5:27 PM
BioSpecifics Technologies (Issuer)
Chao Jennifer M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/19/2018
5:26 PM
BioSpecifics Technologies (Issuer)
Mattila Jyrki (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2018
2:18 PM
BioSpecifics Technologies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/14/2018
7:15 AM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/13/2018
3:04 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/16/2018
4:17 PM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/13/2018
3:59 PM
BioSpecifics Technologies (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G/A
View Filing
02/09/2018
12:15 PM
BioSpecifics Technologies (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
View Filing
01/30/2018
5:03 AM
BioSpecifics Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/23/2018
4:09 PM
BioSpecifics Technologies (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
View Filing
12/18/2017
4:12 PM
BioSpecifics Technologies (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G
View Filing
This page was last updated on 5/23/2019 by MarketBeat.com Staff

Featured Article: What is the Rule of 72?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel